The Effect of Vedolizumab on Spondyloarthritis Symptoms in a Cohort of Inflammatory Bowel Disease Patients

MLA

Sinakhanım Huseynzada, et al. “The Effect of Vedolizumab on Spondyloarthritis Symptoms in a Cohort of Inflammatory Bowel Disease Patients.” European Journal of Rheumatology, vol. 10, no. 2, Apr. 2023, pp. 50–56. EBSCOhost, https://doi.org/10.5152/eurjrheum.2023.22049.

APA

Sinakhanım Huseynzada, Tuba Yüce İnel, Farid Hajiyev, Aydan Köken Avşar, Ali Balcı, Hale Akpınar, Fatoş Önen, & İsmail Sarı. (2023). The Effect of Vedolizumab on Spondyloarthritis Symptoms in a Cohort of Inflammatory Bowel Disease Patients. European Journal of Rheumatology, 10(2), 50–56. https://doi.org/10.5152/eurjrheum.2023.22049

Chicago

Sinakhanım Huseynzada, Tuba Yüce İnel, Farid Hajiyev, Aydan Köken Avşar, Ali Balcı, Hale Akpınar, Fatoş Önen, and İsmail Sarı. 2023. “The Effect of Vedolizumab on Spondyloarthritis Symptoms in a Cohort of Inflammatory Bowel Disease Patients.” European Journal of Rheumatology 10 (2): 50–56. doi:10.5152/eurjrheum.2023.22049.